1.A Nationwide Survey of Lymphangioleiomyomatosis in Korea: Recent Increase in Newly Diagnosed Patients.
Hye Yun PARK ; Hae Seong NAM ; Man Pyo CHUNG ; Sung Hwan JEONG ; Yu Jin KIM ; Seung Ick CHA ; Young Whan KIM ; Jong Sun PARK ; Soo Taek UH ; Choon Sik PARK ; Moo Suk PARK ; Ji Ae MOON ; Kyung Soo JUNG ; Yang Jin JEGAL ; Dong Soon KIM ; Jin Woo SONG ; Ho Kee YUM ; Young Bum PARK
Journal of Korean Medical Science 2010;25(8):1182-1186
In 2007, the Korean Interstitial Lung Disease Society had collected clinical data of patients who have diagnosed as Lymphangioleiomyomatosis (LAM) since 1990 through nationwide survey, which showed that LAM patients had increased sharply after 2004. The present study was performed to show the clinical features of Korean patients with LAM, and to establish the reason for the recent increase in the diagnosis. All 63 patients were women and the mean age at diagnosis was 36 yr. The most common presenting symptom was dyspnea and 8 patients had tuberous sclerosis complex. The survival rate at 5 yr after diagnosis was 84%. Compared with patients diagnosed after 2004 (n=34), the patients diagnosed before 2004 (n=29) complained with dyspnea more (P=0.016) and had lower FEV1% predicted (P=0.003), and DLco% predicted (P=0.042). The higher proportion of patients diagnosed after 2004 showed the normal chest radiography, and they were detected by routine chest CT screening (P=0.016). This study showed that clinical features of Korean patients with LAM were not different from those reported elsewhere. It is concluded that the reason for the increase of newly diagnosed patients is the result of increase in detection of the early stage LAM by the widespread use of chest CT screening.
Adult
;
Aged
;
Early Diagnosis
;
Female
;
Humans
;
Lung Neoplasms/*diagnosis/mortality/radiography
;
Lymphangioleiomyomatosis/*diagnosis/mortality/radiography
;
Middle Aged
;
Republic of Korea
;
Respiratory Function Tests
;
Survival Rate
;
Tomography, X-Ray Computed
2.A Case of Hypertrophic Osteoarthropathy Associated with Nasopharyngeal Carcinoma in a Child.
Seung Hyun SOHN ; Seung Hoon RYU ; Hyuk Chan KWON ; Mi Kyoung PARK ; Sung Won LEE ; Won Tae CHUNG
Journal of Korean Medical Science 2003;18(5):761-763
Hypertrophic osteoarthropathy is characterized by clubbing of the digital tips and periosteal reaction of long bones. Most of the cases are associated with malignancy or other conditions such as congenital heart disease, liver cirrhosis, pulmonary fibrosis, biliary atresia, and gastrointestinal polyps. Hypertrophic osteoarthropathy associated with malignancy is rare in children. A few cases of hypertrophic osteoarthropathy in children with nasopharyngeal carcinoma have been reported, however, there has been no report of such case in Korea. We present a case of hypertrophic osteoarthropathy associated with nasopharyngeal carcinoma with lung metastasis in a 14-yr-old boy. In this case, hypertrophic osteoarthropathy regressed after intensive chemotherapy, but subsequently the patient died of progressive lung metastasis.
Adolescent
;
Bone and Bones/radiography
;
Carcinoma/*diagnosis/mortality
;
Disease Progression
;
Fatal Outcome
;
Human
;
Joint Diseases/pathology
;
Lung Neoplasms/mortality/*secondary
;
Male
;
Nasopharyngeal Neoplasms/*diagnosis/mortality
;
Neoplasm Metastasis
;
Osteoarthropathy, Primary Hypertrophic/*diagnosis/mortality/radiography
;
Prognosis
3.The Korean guideline for lung cancer screening.
Seung Hun JANG ; Seungsoo SHEEN ; Hyae Young KIM ; Hyeon Woo YIM ; Bo Young PARK ; Jae Woo KIM ; In Kyu PARK ; Young Whan KIM ; Kye Young LEE ; Kyung Soo LEE ; Jong Mog LEE ; Bin HWANGBO ; Sang Hyun PAIK ; Jin Hwan KIM ; Nak Jin SUNG ; Sang Hyun LEE ; Seung Sik HWANG ; Soo Young KIM ; Yeol KIM ; Won Chul LEE ; Sook Whan SUNG
Journal of the Korean Medical Association 2015;58(4):291-301
Lung cancer is the leading cause of cancer death in many countries, including Korea. The majority of patients are inoperable at the time of diagnosis because symptoms are typically manifested at an advanced stage. A recent large clinical trial demonstrated significant reduction in lung cancer mortality by using low dose computed tomography (LDCT) screening. A Korean multisociety collaborative committee systematically reviewed the evidences regarding the benefits and harms of lung cancer screening, and developed an evidence-based clinical guideline. There is high-level evidence that annual screening with LDCT can reduce lung cancer mortality and all-cause mortality of high-risk individuals. The benefits of LDCT screening are modestly higher than the harms. Annual LDCT screening should be recommended to current smokers and ex-smokers (if less than 15 years have elapsed after smoking cessation) who are aged 55 to 74 years with 30 pack-years or more of smoking-history. LDCT can discover non-calcified lung nodules in 20 to 53% of the screened population, depending on the nodule positivity criteria. Individuals may undergo regular LDCT follow-up or invasive diagnostic procedures that lead to complications. Radiation-associated malignancies associated with repetitive LDCT, as well as overdiagnosis, should be considered the harms of screening. LDCT should be performed in qualified hospitals and interpreted by expert radiologists. Education and actions to stop smoking must be offered to current smokers. Chest radiograph, sputum cytology at regular intervals, and serum tumor markers should not be used as screening methods. These guidelines may be amended based on several large ongoing clinical trial results.
Biomarkers, Tumor
;
Diagnosis
;
Early Detection of Cancer
;
Education
;
Follow-Up Studies
;
Humans
;
Korea
;
Lung
;
Lung Neoplasms*
;
Mass Screening*
;
Mortality
;
Radiography, Thoracic
;
Smoke
;
Smoking
;
Sputum
4.Lung Cancer Screening with Low-dose Computed Tomography.
Tuberculosis and Respiratory Diseases 2004;57(2):118-124
Lung cancer is the leading cause of cancer death for men and women in the industrialized world. It is desirable to detect disease at a stage when it is not causing symptoms and when control or cure is possible. If the screening test detects patients with the disease at an early stage, they can be examined to confirm the diagnosis and intervention can alter the natural history of the disease. The results of screening programs designed to detect early lung cancer using either conventional chest radiograph or sputum cytology are disappointing for a diagnostic screening test. Because of advances in helical CT imaging techniques, screening for lung cancer has been suggested as a possible method of improving outcome. Findings in recent publications suggest that substantial dose reduction is possible in chest CT. The advantages of low-dose CT are more sensitive than chest radiograph for detecting small pulmonary nodules that may be lung cancers, shorter scanning time than conventional chest CT scan without intravenous contrast injection, cheaper cost than standard CT, low radiation dose. However, the true clinical significance of the small tumors found by screening is still unknown, and their effect on mortality awaits future investigation. Furthermore, in addition to detecting an increased number of lung cancers, low-dose CT found at least one indeterminate nodule in many of all screened patients. The majority should be benign but evaluation of all these indeterminate nodules is not a trivial problem in routine practice. In conclusion, lung cancer screening with low-dose CT is a complex subject. The true effectiveness of lung cancer screening (a reduction in mortality from lung cancer) with low-dose CT can be determined through well-designed randomized control trials with enrolment of appropriate subjects.
Diagnosis
;
Early Detection of Cancer
;
Female
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Male
;
Mass Screening*
;
Mortality
;
Natural History
;
Radiography, Thoracic
;
Sputum
;
Tomography, Spiral Computed
;
Tomography, X-Ray Computed